RECENT NEWS
Honeycomb Biotechnologies and Revvity expand single-cell research
Revvity, in collaboration with single-cell genomics company Honeycomb Biotechnologies, has announced the launch of a suite of new solutions and services that expand the frontiers of single-cell biology: the HIVE CLX Single-Cell RNAseq Solution, BeeNetPLUS analysis workflow.
IBMS Congress – early booking rates ending
If you haven’t already booked your tickets for IBMS Congress, then now is the time as early booking rates end this weekend, on Sunday 2 July.
Data presented showing progress in Breath Biopsy tests for liver cirrhosis and NASH
Owlstone Medical, the developer of Breath Biopsy for applications in early disease detection and precision medicine, has announced new data on the development of novel tests for the detection of liver disease.
NHS staff switching to improved patient record service
NHS England is encouraging all health and care professionals to move to the new version of an NHS patient record service to enhance the way national patient medical information can be accessed.
King’s Fund report gives NHS mixed bill of health
The NHS is ‘neither a leader nor a laggard’ when compared to health care systems of similar countries, though on some critical measures of resources and performance the UK is falling well-below average, according to a major new report from The King’s Fund.
Lunaphore to be acquired by Bio-Techne
Lunaphore Technologies, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, has reached an agreement to be acquired by Bio-Techne Corporation, a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostics communities.
NanoDrop at-home blood-sampling device earns CE Mark
Thorne HealthTech has announced that its NanoDrop device has received CE Mark certification and has successfully fulfilled the European Union's relevant performance, safety and product requirements.
FUJIFILM Irvine Scientific expands capabilities of Life Whisperer IVF platform
FUJIFILM Irvine Scientific has added the Life Whisperer Genetics module to its Life Whisperer software package (launched in 2021), enabling non-invasive evaluation of embryo genetic integrity during in vitro fertilisation (IVF).
Aiosyn launches AI-powered mitosis detection solution
Aiosyn, a medical software company specialising in AI-powered pathology solutions, has released its first AI algorithm in its Mitosis product family: Aiosyn Mitosis Research. The innovative deep-learning algorithm is designed to automatically scan for cells undergoing division to assist research pathology laboratories with mitotic figure detection in whole-slide images from cancer biopsies and resections.
NHS England appoints Chief Information Officer
NHS England has appointed a new Chief Information Officer to oversee digital technology across the health service. John Quinn’s key responsibilities will include running and evolving the NHS’s critical technical infrastructure and managing cyber security for national services.
Randox acquires microfluidic tools and impedance flow cytometer developer Cellix
Global diagnostics company Randox has announced the completion of its acquisition of Cellix, a Dublin-based company that develops microfluidic tools and impedance flow cytometers for cell analysis.
Evident launches Slideview DX for microscope-quality images
The new Evident Slideview DX VS-M1 whole slide imaging system is a digital pathology solution that delivers high-quality slide images at high speed, helping pathologists make diagnoses quickly and efficiently. Built with renowned optics and advanced digital technology, the Slideview DX slide scanner is a complete digital pathology solution.
Mindpeak and Proscia partner to improve cancer diagnosis with AI
Mindpeak, a leading provider of artificial intelligence (AI) for pathology, and Proscia, a leading provider of digital and computational pathology solutions, have announced a partnership to broaden access to improved diagnosis for cancer patients.Through the collaboration, the companies lay the foundation for delivering tightly integrated AI-powered workflows that enable pathologists to provide more efficient, informed, and reproducible clinical decisions.
Yourgene Health demonstrates successful use of EDTA tubes for prenatal testing
Yourgene Health, a leading international molecular diagnostics group, has presented data demonstrating that prolonged storage of blood in EDTA tubes is compatible with non-invasive prenatal testing (NIPT) when using size selection to enrich the fetal fraction.
Sussex Pathology Network to deploy Clinisys LIMS
The Sussex Pathology Network has chosen Clinisys for a laboratory information management system (LIMS) that will help its laboratories to collaborate, building on the supportive relationship that developed during the COVID-19 pandemic. A single, hosted instance of WinPath Enterprise will replace the existing four live LIMS systems in use at the three trusts and seven laboratories within the network, of which two are at the end of their life.
H.E.L Group expands into new purpose-designed facilities
H.E.L Group, a global developer and manufacturer of innovative laboratory tools for process optimisation, safety, and scale-up, today announced it will relocate its Greater London global headquarters from Borehamwood to Hemel Hempstead, over summer 2023. Overseen by interim Operational Director, Damian Slater, the move to new purpose-designed facilities supports the company’s continued expansion and plans for future growth.
RCPath celebrates National Pathology Week
This week The Royal College of Pathologists is celebrating National Pathology Week (NPW) - its annual celebration of pathology, highlighting the important contribution pathologists make to healthcare.
‘POCT: The power to disrupt’ comes to London
The next in the series of POCT events hosted by Thornhill Healthcare has been announced for London on 23 August, taking place at The Royal College of Pathologists in Aldgate.
Aiosyn expands its AI-powered QC for digital pathology to support IHC staining
Aiosyn, a software company that develops AI-powered pathology solutions, has announced the latest advancement in its automated quality control (QC) algorithm. Aiosyn’s QC solution, AiosynQC, is now fully compatible with immunohistochemistry (IHC) slides, in addition to haematoxylin and eosin (H&E) slides.
ProciseDx acquired by Biosynex to progress drug monitoring tests
ProciseDx has announced that it is being acquired by Biosynex, a French diagnostics company that specialises in point-of-care testing. With the support of the Biosynex Group, ProciseDx expects to commercialise the first FDA-approved infliximab and adalimumab drug monitoring tests later this year.
Featured Supplier
The laboratory business is under pressure to change. Market consolidation, standardisation, advanced automation, genomic testing, and the increase in point-of-care testing are driving major shifts in where, when, and how testing takes place. To not only survive, but to thrive, laboratories need a new generation of informatics solutions with...
Upcoming Events
IBMS Congress 2023 - Linking learning to the laboratory
ICC Birmingham
25-28 September 2023
BIVDA Annual Regulatory Affairs Seminar
The Balmoral, 1 Princes Street, Edinburgh, EH2 2EQ
3-4 October 2023
Drug Discovery 2023
ACC Exhibition Centre, Liverpool
18-19 October
MEEGID XVI
Hilton Dresden, Germany
14-17 November 2023
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
